RB1 and diffuse large B-cell lymphoma: In DLBCL models, expression of miR-155 inhibited the activation of the retinoblastoma protein (RB), reducing the abundance of the inhibitory pRB-E2F1 complex and limiting G0/G1 arrest through the release of E2F1 [72].